Clinical pharmacokinetics of bambuterol

Clinical Pharmacokinetics

Volumn 31, Issue 4, 1996, Pages 246-256

  Sitar, Daniel S ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BAMBUTEROL; CHOLINESTERASE; PRODRUG; SALBUTAMOL; SUXAMETHONIUM; TERBUTALINE;

AREA UNDER THE CURVE; ASTHMA; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ELIMINATION; DRUG HYDROLYSIS; DRUG METABOLISM; DRUG OXIDATION; DRUG STABILITY; DRUG TOXICITY; GENE EXPRESSION; HEADACHE; HEART PALPITATION; HUMAN; HYPOTENSION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; STEADY STATE; TACHYCARDIA; TREMOR;

EID: 0029797109     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-199631040-00002     Document Type: Review

References (48)

1. Sitar DS, Aoki FY, Warren CP, et al. A placebo-controlled dose-finding study with bambuterol in elderly patients with asthma. Chest 1993; 103: 771-6
2. Svennson L-Å, Tunek A. The design and bioactivation of pre-systemically stable prodrugs. Drug Metab Rev 1988; 19: 165-94
3. Tunek A, Svennson L-Å. Bambuterol, a carbamate ester prodrug of terbutaline, as inhibitor of cholinesterases in human blood. Drug Metab Dispos 1988; 16: 759-64
4. 3H-bambuterol, a carbamate prodrug of terbutaline, in blood from humans and laboratory animals in vitro. Biochem Pharmacol 1988; 37: 3867-76
5. a. Biochem Pharmacol 1991; 41: 345-8
6. Persson H, Olsson T. Some pharmacological properties of terbutaline (INN), 1-(3,5-dihydroxyphenyl)-2-(t-butylamino)-ethanol. A new sympathomimetic β-receptor-stimulating agent. Acta Med Scand 1979; Suppl. 512: 11-9
7. Brogden RN, Speight TM, Avery GS. Terbutaline: a preliminary report of its pharmacological properties and therapeutic efficacy in asthma. Drugs 1973; 6: 324-32
8. Nilsson HT, Persson K, Tegnér K. The metabolism of terbutaline in man. Xenobiotica 1972; 2: 363-75
9. Lefrink JG, Wagemaker-Engels I, Maees RAA, et al. Quantitative analysis of terbutaline in serum and urine at therapeutic levels using gas chromatography-mass spectrometry. J Chromatogr 1977; 143: 299-305
10. Clare RA, Davies DS, Baillie TA. The analysis of terbutaline in biological fluids by gas chromatography electron impact mass spectrometry. Biomed Mass Spectrum 1979; 6: 31-7
11. Jacobsson S-E, Jönsson S, Lindberg C, et al. Determination of terbutaline in plasma by gas chromatography chemical ionization mass spectrometry. Biomed Mass Spectrom 1980; 7: 265-8
12. Edholm L-E, Kennedy B-M, Bergquist S. Automated analysis of terbutaline (Bricanyl®) in human plasma with liquid chromatography and electrochemical detection using column switching (multidimensional chromatography). Chromatographia 1982; 16: 341-4
13. Edholm L-E, Kennedy B-M, Bergquist S. Multidimensional column liquid chromatography with electrochemical detection for the analysis of terbutaline in human plasma. Eur J Resp Dis 1984; 65 Suppl. 134: 33-40
14. Kennedy B-M, Blomgren A, Deholm L-E, et al. Quantitative determination of terbutaline in human plasma after administration of bambuterol using coupled columns and electrochemical detection. Chromatographia 1987; 24: 895-9
15. Sitar DS, Piafsky KM, Ogilvie RI. The relative bioavailability of terbutaline (Bricanyl®) elixir and tablet formulations. Curr Ther Res 1976; 19: 266-73
16. Nyberg L. Pharmacokinetic parameters of terbutaline in healthy man: an overview. Eur J Respir Dis 1984; 65 Suppl. 134: 149-60
17. Pedersen BK, Laursen LC, Gnosspelius Y, et al. Bambuterol: effects of a new anti-asthmatic drug. Eur J Clin Pharmacol 1985; 29: 425-7
18. Vilsvik JS, Langaker O, Persson G, et al. Bambuterol: a new long acting bronchodilating prodrug. Ann Allergy 1991; 66: 315-9
19. Sandström T, Åsander L, Clemmensen IH, et al. Bambuterol: clinical effects of different doses of a long-acting bronchodilator prodrug. Respiration 1988; 53: 31-6
20. Holstein-Rathlou N-H, Laursen LC, Madsen F, et al. Bambuterol: dose response study of a new terbutaline prodrug in asthma. Eur J Clin Pharmacol 1986; 30: 7-11
21. Sitar DS, Warren CP, Aoki FY. Pharmacokinetics and pharmacodynamics of bambuterol, a long-acting bronchodilator prodrug of terbutaline, in young and elderly patients with asthma. Clin Pharmacol Ther 1992; 52: 297-306
22. D'Alonzo GE, Smolensky MH, Feldman S, et al. Bambuterol in the treatment of asthma: a placebo-controlled comparison of once-daily morning vs evening administration. Chest 1995; 107: 406-12
23. Fagerström P-O. Pharmacokinetics of terbutaline after parenteral administration. Eur J Resp Dis 1984; 65 Suppl. 134: 101-10
24. Ryrfeldt Å, Nilsson E, Tunek A, et al. Bambuterol: uptake and metabolism in guinea pig isolated lungs. Pharm Res 1988; 5: 151-5
25. Bodin NO, Hansson E, Ramsay CH, et al. The tissue distribution of 3H-terbutaline (Bricanyl®) in mice. Acta Physiol Scand 1972; 84: 40-7
26. Ryrfeldt Å, Ramsay CH. Distribution of terbutaline. Eur J Resp Dis 1984; 65 Suppl. 134: 63-72
27. Lindberg C, Roos C, Tunek A, et al. Metabolism of bambuterol in rat liver microsomes: identification of hydroxylated and demethylated products by liquid chromatography mass spectrometry. Drug Metab Dispos 1989; 17: 311-22
28. Nyberg L. Pharmacokinetic properties of bambuterol in solution and tablets-basis for once daily dosage in asthma. Acta Pharmacol Toxicologica 1986; 59 Suppl. V: 229
29. 2-agonist bambuterol in asthmatic patients. Eur Respir J 1995; 8: 34-9
30. Burr ML, Charles TJ, Roy K, et al. Asthma in the elderly: an epidemiological survey. BMJ 1979; 1: 1041-7
31. Petrie GR, Chookang JY, Hassan WU, et al. Bambuterol: effective in nocturnal asthma. Respir Med 1993; 87: 581-5
32. Clemmensen IH, Pedersen BK, Ravn S, et al. Bambuterol: clinical effects of three doses of bambuterol once daily in asthmatic patients. Allergy 1988; 43: 573-6
33. Persson G, Gnosspelius Y, Anehus S. Comparison between a new once-daily, bronchodilating drug, bambuterol, and terbutaline sustained-release, twice daily. Eur Respir J 1988; 1: 223-6
34. Fugleholm AM, Ibsen TB, Laxmyr L, et al. Therapeutic equivalence between bambuterol, 10mg once daily, and terbutaline controlled release, 5mg twice daily, in mild to moderate asthma. Eur Respir J 1993; 6: 1474-8
35. Persson G, Pahlm O, Gnosspelius Y. Oral bambuterol versus terbutaline in patients with asthma. Curr Ther Res 1995; 56: 457-65
36. Wempe JB, Tammeling EP, Postma DS, et al. Effects of budesonide and bambuterol on circadian variation of airway responsiveness and nocturnal symptoms of asthma. J Allergy Clin Immunol 1992; 90: 349-57
37. Gunn SD, Ayres JG, McConchie SM, et al. Comparison of the efficacy, tolerability and patient acceptability of once-daily bambuterol tablets against twice-daily controlled release salbutamol in nocturnal asthma. Eur J Clin Pharmacol 1995; 48: 23-8
38. Larsén K, Schmekel B. Tremor in healthy volunteers after bambuterol and terbutaline CR-tablets. Eur J Clin Pharmacol 1993; 45: 303-5
39. Deacon SP. Salbutamol and hypokalemia. Lancet 1976; I: 1302
40. Leitch AG, Clancy LJ, Costello JF, et al. Effect of intravenous infusion of salbutamol on ventilatory response to carbon dioxide and hypoxia and on heart rate and plasma potassium in normal men. BMJ 1976; 1: 365-7
41. Wempe JB, Tammeling EP, Koëter GH, et al. Blood eosinophil numbers and activity during 24 hours: effects of treatment with budesonide and bambuterol. J Allergy Clin Immunol 1992; 90: 757-65
42. Fisher DM, Caldwell JE, Sharma M, et al. The influence of bambuterol (carbamylated terbutaline) on the duration of action of succinylcholine-induced paralysis in humans. Anesthesiology 1988; 69: 757-9
43. Staun P, Lennmarken C, Eriksson LI, et al. The influence of 10mg and 20mg of bambuterol on the duration of succinylcholine-induced neuromuscular blockade. Acta Anaesthesiol Scand 1990; 34: 498-500
44. Bang U, Viby-Mogensen J, Wirén JE, et al. The effect of bambuterol (carbamylated terbutaline) on plasma cholinesterase activity and suxamethonium-induced neuromuscular blockade in genotypically normal patients. Acta Anaesthesiol Scand 1990; 34: 596-9
45. Hang U, Viby-Mogensen J, Wirén JE. The effect of bambuterol on plasma cholinesterase activity and suxamethonium-induced neuromuscular blockade in subjects heterozygous for abnormal plasma cholinesterase. Acta Anaesthesiol Scand 1990; 34: 600-4
46. Asthma at night [editorial]. Lancet 1983; I: 220-2
47. Tilles SA, Nelson HS. Long-acting inhaled beta agonists. J Asthma 1995; 32: 397-404
48. Bhagat R, Kalra S, Swystun VA, et al. Rapid onset of tolerance to the bronchoprotective effect of salmeterol. Chest 1995; 108: 1235-39